Nadolol
- Nadolol NADOLOL 20 mg/1 Greenstone LLC
- NADOLOL NADOLOL 20 mg/1 VGYAAN Pharmaceuticals LLC
- NADOLOL NADOLOL 20 mg/1 Alembic Pharmaceuticals Inc.
- Nadolol NADOLOL 20 mg/1 Marlex Pharmaceuticals Inc
- Nadolol NADOLOL 20 mg/1 American Health Packaging
- Nadolol NADOLOL 20 mg/1 Exelan Pharmaceuticals Inc.
- Nadolol NADOLOL 20 mg/1 Major Pharmaceuticals
- NADOLOL NADOLOL 20 mg/1 Alembic Pharmaceuticals Limited
- Nadolol NADOLOL 20 mg/1 Sandoz Inc
- Nadolol NADOLOL 20 mg/1 Aurobindo Pharma Limited
- Corgard NADOLOL 20 mg/1 USWM, LLC
- Nadolol NADOLOL 20 mg/1 Cipla USA Inc.
- Nadolol NADOLOL 20 mg/1 Zydus Lifesciences Limited
- Nadolol NADOLOL 20 mg/1 BluePoint Laboratories
- Nadolol NADOLOL 20 mg/1 Aurobindo Pharma Limited
- Nadolol NADOLOL 20 mg/1 Zydus Pharmaceuticals USA Inc.
Summary of product characteristics
Effective Time
20221031
Version
4
Spl Product Data Elements
Nadolol Nadolol NADOLOL NADOLOL ANHYDROUS CITRIC ACID CELLULOSE, MICROCRYSTALLINE FERRIC OXIDE YELLOW MAGNESIUM STEARATE POVIDONE SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN YELLOW ROUND N;40 Nadolol Nadolol NADOLOL NADOLOL ANHYDROUS CITRIC ACID CELLULOSE, MICROCRYSTALLINE FD&C BLUE NO. 2 MAGNESIUM STEARATE POVIDONE SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN BLUE ROUND N;80 Nadolol Nadolol NADOLOL NADOLOL ANHYDROUS CITRIC ACID CELLULOSE, MICROCRYSTALLINE MAGNESIUM STEARATE POVIDONE SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN OFF-WHITE ROUND N;20
Application Number
ANDA207761
Brand Name
Nadolol
Generic Name
Nadolol
Product Ndc
70771-1089
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1089-9 Nadolol tablets, 20 mg Rx only 90 tablets NDC 70771-1090-9 Nadolol tablets, 40 mg Rx only 90 tablets NDC 70771-1091-9 Nadolol tablets, 80 mg Rx only 80 tablets Nadolol tablets Nadolol tablets Nadolol tablets
Drug section
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.